Use of COVID-19 Vaccines in the United States

Interim Clinical Considerations

Summary of recent changes (last updated January 27, 2023):
  • As of January 26, 2023, EVUSHELDTM is not currently authorized for SARS-CoV-2 pre-exposure prophylaxis in the United States.